Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

A comprehensive review on adult onset Still's disease
Roberto Giacomelli, Piero Ruscitti, Yehuda Shoenfeld
Journal of Autoimmunity (2018) Vol. 93, pp. 24-36
Closed Access | Times Cited: 345

Showing 1-25 of 345 citing articles:

Adult-onset Still's disease in focus: Clinical manifestations, diagnosis, treatment, and unmet needs in the era of targeted therapies
Petros Efthimiou, Apostolos Kontzias, Peter Hur, et al.
Seminars in Arthritis and Rheumatism (2021) Vol. 51, Iss. 4, pp. 858-874
Open Access | Times Cited: 139
Recent advances and evolving concepts in Still’s disease
Piero Ruscitti, Luca Cantarini, Peter A. Nigrović, et al.
Nature Reviews Rheumatology (2024) Vol. 20, Iss. 2, pp. 116-132
Closed Access | Times Cited: 30
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm
Piero Ruscitti, Onorina Berardicurti, Paola Di Benedetto, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 95
Adult-Onset Still’s Disease: Clinical Aspects and Therapeutic Approach
Stylianos Tomaras, Carl Christoph Goetzke, Tilmann Kallinich, et al.
Journal of Clinical Medicine (2021) Vol. 10, Iss. 4, pp. 733-733
Open Access | Times Cited: 63
Ferritin triggers neutrophil extracellular trap-mediated cytokine storm through Msr1 contributing to adult-onset Still’s disease pathogenesis
Jinchao Jia, Mengyan Wang, Jianfen Meng, et al.
Nature Communications (2022) Vol. 13, Iss. 1
Open Access | Times Cited: 44
Autoimmune liver diseases in systemic rheumatic diseases
Chrong‐Reen Wang, Hung‐Wen Tsai
World Journal of Gastroenterology (2022) Vol. 28, Iss. 23, pp. 2527-2545
Open Access | Times Cited: 43
Autoimmune inflammatory rheumatic diseases post-COVID‐19 vaccination
Azam Safary, Kamal Esalatmanesh, Amir Taher Eftekharsadat, et al.
International Immunopharmacology (2022) Vol. 110, pp. 109061-109061
Open Access | Times Cited: 40
Management of adult-onset Still's disease: evidence- and consensus-based recommendations by experts
Helen L. Leavis, Paul Van Daele, Catharina M. Mulders‐Manders, et al.
Lara D. Veeken (2023) Vol. 63, Iss. 6, pp. 1656-1663
Open Access | Times Cited: 24
Autoinflammatory Diseases – A Review
Jason An, Ashish Marwaha, Ronald M. Laxer
The Journal of Rheumatology (2024) Vol. 51, Iss. 9, pp. 848-861
Open Access | Times Cited: 12
Drug Reaction with Eosinophilia and Systemic Symptoms (DReSS): How Far Have We Come?
Sylvia Aidé Martínez‐Cabriales, Fabian Rodríguez-Bolaños, Neil H. Shear
American Journal of Clinical Dermatology (2019) Vol. 20, Iss. 2, pp. 217-236
Closed Access | Times Cited: 69
Pathogenesis, disease course, and prognosis of adult-onset Still's disease: an update and review
Meng‐Yan Wang, Jinchao Jia, Chengde Yang, et al.
Chinese Medical Journal (2019) Vol. 132, Iss. 23, pp. 2856-2864
Open Access | Times Cited: 62
Systemic immune-inflammation index combined with ferritin can serve as a reliable assessment score for adult-onset Still’s disease
Ji-Won Kim, Ju‐Yang Jung, Chang‐Hee Suh, et al.
Clinical Rheumatology (2020) Vol. 40, Iss. 2, pp. 661-668
Closed Access | Times Cited: 55
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations
Piero Ruscitti, Paola Di Benedetto, Onorina Berardicurti, et al.
Scientific Reports (2020) Vol. 10, Iss. 1
Open Access | Times Cited: 52
The treatment of adult-onset Still's disease with anakinra, a recombinant human IL-1 receptor antagonist: a systematic review of literature
Roberto Giacomelli, Jurgen Sota, Piero Ruscitti, et al.
Clinical and Experimental Rheumatology (2021) Vol. 39, Iss. 1, pp. 187-195
Open Access | Times Cited: 47
First manifestation of adult-onset Still's disease after COVID-19
Anna D Bamidis, Philipp Koehler, Veronica Di Cristanziano, et al.
The Lancet Rheumatology (2021) Vol. 3, Iss. 5, pp. e319-e321
Open Access | Times Cited: 45
Working and safety profiles of JAK/STAT signaling inhibitors. Are these small molecules also smart?
Elvira Favoino, Marcella Prete, Giacomo Catacchio, et al.
Autoimmunity Reviews (2021) Vol. 20, Iss. 3, pp. 102750-102750
Closed Access | Times Cited: 42
Adult-Onset Still’s Disease—A Complex Disease, a Challenging Treatment
Luana Andreea Macovei, Alexandra Burlui, Ioana Bratoiu, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 21, pp. 12810-12810
Open Access | Times Cited: 35
Refractory systemic onset juvenile idiopathic arthritis: current challenges and future perspectives
William G Ambler, Kabita Nanda, Karen Onel, et al.
Annals of Medicine (2022) Vol. 54, Iss. 1, pp. 1839-1850
Open Access | Times Cited: 29
Parenchymal lung disease in adult onset Still’s disease: an emergent marker of disease severity—characterisation and predictive factors from Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort of patients
Piero Ruscitti, Onorina Berardicurti, Daniela Iacono, et al.
Arthritis Research & Therapy (2020) Vol. 22, Iss. 1
Open Access | Times Cited: 44
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still’s disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort
Paola Di Benedetto, Paola Cipriani, Daniela Iacono, et al.
PLoS ONE (2020) Vol. 15, Iss. 7, pp. e0235326-e0235326
Open Access | Times Cited: 43
Disparities in the prevalence of clinical features between systemic juvenile idiopathic arthritis and adult-onset Still’s disease
Piero Ruscitti, Valentina Natoli, Alessandro Consolaro, et al.
Lara D. Veeken (2022) Vol. 61, Iss. 10, pp. 4124-4129
Open Access | Times Cited: 27
Adult-onset Still’s disease: A disease at the crossroad of innate immunity and autoimmunity
S. Rao, Lemuel Shui‐Lun Tsang, Ming Zhao, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 25
A review of the pleiotropic actions of the IFN-inducible CXC chemokine receptor 3 ligands in the synovial microenvironment
Luna Dillemans, Lien De Somer, Barbara Neerinckx, et al.
Cellular and Molecular Life Sciences (2023) Vol. 80, Iss. 3
Open Access | Times Cited: 14
Cardiac Involvement in Patients With Multisystem Inflammatory Syndrome in Adults
Giulia La Vecchia, Marco Giuseppe Del Buono, Aldo Bonaventura, et al.
Journal of the American Heart Association (2024) Vol. 13, Iss. 4
Open Access | Times Cited: 5
Pathogenesis of adult onset still’s disease: current understanding and new insights
Piero Ruscitti, Roberto Giacomelli
Expert Review of Clinical Immunology (2018) Vol. 14, Iss. 11, pp. 965-976
Closed Access | Times Cited: 44
Page 1 - Next Page

Scroll to top